Barbara Davis Center for Diabetes, University of Colorado, 1775 Aurora Court, USA
Mini Review
Arising Advancements and Therapeutics for Type 1 Diabetes
Author(s): Halis Kaan*
Type 1 diabetes (T1D) is a complex autoimmune disorder characterized by the destruction of insulin-producing pancreatic beta cells, necessitating lifelong insulin replacement therapy. Recent years have witnessed significant strides in the understanding, diagnosis, and management of T1D. This review provides a comprehensive overview of emerging advancements and innovative therapeutics poised to revolutionize the landscape of T1D care. Beta Cell Regeneration and Replacement: The advent of stem cellbased therapies and islet transplantation techniques show promise in restoring beta cell function. Recent breakthroughs in generating functional beta cells from various cellular sources offer new avenues for achieving insulin independence.
Immunomodulatory Interventions: Targeted immunotherapies aimed at preserving beta cell mass and function have gained traction. Monoclonal antibodi.. View More»
DOI:
10.35248/2155-6156.10001038
